来自MSN1 个月
Novo Nordisk slashes U.S. list prices for insulin meds Tresiba, Fiasp
and Fiasp (insulin aspart), by more than 70% starting Jan. 1, 2026. Fiasp's price will be reduced by 75%, making it the same price as NovoLog (insuin aspart), while Tresiba's price will be reduced ...